Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +1.59% to 10412.24, DAX +2.39% to 23968.63, CAC40 +1.79% to 8057.36, STOXX 600 +1.88% to 606.12

Mar 10 ,2026

  • Synopsis:

    • European equities closed higher following sharp retreat in oil prices. Basic resources, banks and technology were the best performing sectors, food and beverage, energy and health care the main laggards. Follows a lower close on Monday with Energy the only sector in the black.

    • European equities tracked cautious global relief rally. Risk sentiment supported into Tuesday as President Trump declared Iran conflict "very complete", said it would end "very soon" while simultaneously vowing to press on until Iran decisively defeated and threatening to strike harder if Iran disrupts oil flows. Oil prices declined substantially although trade remains volatile. Iran's Revolutionary Guard defiant. Also aiding sentiment was Trump confirming plans for temporary relief from oil-related sanctions and growing speculation of a coordinated G7 strategic reserve release. Attention remains firmly fixed on the Strait of Hormuz, where Gulf production shut-ins are widening, with Trump said to be weighing options including US Navy escorts and a potential takeover of shipping lanes. Situation remains fluid. EU's Dombrovskis said ready to release strategic oil reserves if required

    • On the political calendar, Chancellor Reeves faces MPs' Treasury questions at 11:30 GMT and OBR fields questions on latest economic and fiscal forecast at 14:15 GMT. ECB's Šimkus and Müller said duration of energy shock key, but ECB likely to stay put for now.

    • In macro, German and French Jan trade balances better than expected, recording a bigger surplus of €21.2B vs consensus €15.2B and prior revised to €17.1B from €17.1B and a smaller deficit (€1.8B) vs consensus (€3.4B) and prior revised to (€4.3B) from (€4.8B), respectively. UK consumer spending and consumer confidence slowed in Feb.

    • In corporate news flow, Hugo Boss (BOSS.GR), Volkswagen (VOW.GR), Kuros Biosciences (KURN.SW), Deutsche Beteiligungs (DBAN.GR), Galenica (GALE.SW) posted their latest numbers, together with Lindt & Sprüngli (LISN.SW), Flughafen Zuerich (FHZN.SW) and Partners Group Holding (PGHN.SW). In the UK, Costain (COST.LN), Persimmon (PSN.LN), Domino's Pizza Group (DOM.LN), Spirax (SPX.LN) and Rotork (ROR.LN) also updated investors before the open. Elsewhere, Renault (RNO.FP) launcheed new strategic plan and Airbus (AIR.FP) reported Feb orders.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Basic Resources +4.23%, Banks +3.62%, Technology +2.87%, Ind Goods & Svcs +2.76%, Travel & Leisure +2.51%, Retail +2.33%, Construct & Mtls +2.26%, Autos & Parts +2.17%

      • Underperformers:

        • Food & Beverage (0.23%), Oil & Gas +0.29%, Health Care +0.31%, Media +0.79%, Telecom +0.91%, Chemicals +1.06%, Persnl & HHold Goods +1.41%, Financial Svcs +1.43%, Real Estate +1.68%, Insurance +1.83%, Utilities +1.87%

    • Macro:

      • Geopolitics:

        • European governments probe petrol price gouging and eye ETS changes amid surging energy costs (FT)

        • EU commissioner signals readiness to release strategic oil reserves due to Iran war disruptions (Bloomberg)

      • France:

        • French municipal elections set to test far-right momentum and center alliances ahead of 2027 presidential race (Politico)

      • UK:

        • UK consumer spending slows in February as Middle East war fuels economic pessimism (Reuters)

        • UK consumer confidence plunges amid Iran war oil shock and inflation fears (Bloomberg)

        • UK retail sales growth weakens in February, hit by weather and looming Middle East conflict risks (Retail Week)

        • Rachel Reeves warns families to brace for fresh inflation from Iran war oil price surge (Telegraph)

        • Households face £344 rise in annual energy bills from Iran war gas price surge, Citi warns (Telegraph)

    • Company news:

      • Notable Gainers

        • +17.0% SENS.SW (Sensirion Holding CHF58.10, +8.45) -- FY earnings

        • +16.8% COST.LN (Costain Group £1.99, +0.29) -- FY earnings

        • +12.4% ATORX.SS (Alligator Bioscience SEK0.21, +0.02) -- granted U.S. patent for tetravalent bispecific antibody design

        • +11.6% IDIA.SW (Idorsia CHF4.04, +0.42) -- company and and Pharmalink enter into an exclusive distribution and commercialization agreement for QUVIVIQ in the United Arab Emirates (UAE), Kuwait, Qatar, Oman, and Bahrain

        • +10.6% KURN.SW (Kuros Biosciences CHF29.40, +2.82) -- FY earnings

        • +10.2% AIXA.GR (Aixtron €31.53, +2.93)

        • +9.5% ETL.FP (Eutelsat Communications €2.12, +0.18)

        • +9.3% PRX.NA (Prosus €46.55, +3.97)

        • +9.0% DEZ.GR (Deutz AG €11.09, +0.92)

        • +8.8% DMP.GR (Dermapharm Holding €41.50, +3.35) -- prelim FY earnings; resolves to tender up to 4.3M shares at an offer price of €42.00 per share

        • +8.5% SBRE.LN (Sabre Insurance Group £1.40, +0.11) -- FY earnings

        • +8.1% LHA.GR (Deutsche Lufthansa €8.22, +0.62) -- sector move

        • +6.9% MT.NA (ArcelorMittal €49.21, +3.17)

        • +6.4% WIZZ.LN (Wizz Air Holdings £9.60, +0.58) -- sector move

        • +5.9% GEN.LN (Genuit Group £3.23, +0.18) -- FY earnings

        • +5.9% FR.FP (Valeo SE €10.84, +0.60)

        • +5.7% IAG.LN (International Consolidated Airlines Group £3.78, +0.20) -- sector move

        • +5.6% SAN.SM (Banco Santander €10.00, +0.53)

        • +5.6% PSN.LN (Persimmon £12.92, +0.69) -- FY earnings

        • +5.6% SZG.GR (Salzgitter €47.58, +2.52)

        • +5.6% GNFT.FP (GENFIT €9.39, +0.50) -- issues press release on previously reported FDA orphan designation for NTZ

        • +5.6% JUP.LN (Jupiter Fund Management £1.90, +0.10)

        • +5.4% SECT.B.SS (Sectra SEK224.00, +11.40) -- DNB Carnegie and Stifel upgrades

        • +5.2% SEYE.SS (Smart Eye SEK57.55, +2.85) -- two additional driver monitoring system design wins with European truck OEM

        • +5.2% RR.LN (Rolls-Royce Holdings £13.03, +0.65) -- sector move

        • +5.1% NDX1.GR (Nordex €43.14, +2.08) -- order

        • +5.0% IGD.IM (IGD SIIIQ €3.96, +0.19) -- trading update

        • +4.9% FARN.LN (Faron Pharmaceuticals £0.54, +0.03) -- sets terms for previously announced €40M rights offering through Stifel;

        • +4.8% AZM.IM (Azimut Holding €33.95, +1.55) -- Feb net inflows

        • +4.8% BARC.LN (Barclays £4.16, +0.19)

        • +4.4% HOT.GR (Hochtief €386.60, +16.40) -- contract

        • +4.3% KINV.B.SS (Kinnevik SEK53.48, +2.20) -- letter that responds to the recent short-seller report

        • +4.0% SCATC.NO (Scatec NOK118.40, +4.50) -- starts commercial operation of 60 MW Sidi Bouzid solar power plant in Tunisia

        • +3.8% AF.FP (Air France-KLM €10.07, +0.37) -- sector move

        • +3.6% DBK.GR (Deutsche Bank €27.50, +0.95)

        • +3.5% DIS.IM (D'Amico International Shipping €7.74, +0.27) -- reduction of its average cost of debt

        • +3.5% TUI1.GR (TUI Group €7.14, +0.24) -- sector move

      • Notable Decliners

        • -63.5% VID.LN (Videndum £0.04, -0.06) -- announces refinancing, including £85M placing, equitisation of £23M of existing RCF and write-offs

        • -63.5% VID.LN (Videndum £0.04, -0.06) -- results of £85M placing at An offer price of 270 pence per new ordinary share

        • -21.6% CPI.LN (Capita £2.77, -0.76) -- FY earnings

        • -15.3% TLW.LN (Tullow Oil £0.12, -0.02) -- receives $36M proceeds of Tranche B payment for Kenya assets sale; comments on oil price impact on cash flow guidance

        • -13.4% ROR.LN (Rotork £3.21, -0.49) -- FY earnings

        • -11.0% BRNK.GR (Branicks Group €1.56, -0.19) -- comments on recent trends in connection with announcement on talks with creditors

        • -10.6% EVT.GR (Evotec €4.66, -0.56) -- prelim FY earnings; CMD

        • -8.6% PCELL.SS (PowerCell Sweden SEK15.45, -1.45) -- responds to claims regarding deficient technology

        • -8.5% LISN.SW (Chocoladefabriken Lindt & Spruengli CHF112,000.00, -10,400.00) -- FY earnings; cuts guidance

        • -7.1% CSG.NA (CSG NV €30.35, -2.30) -- statement regarding media report concerning Fbricaa de Municiones de Granada and NSPA

        • -3.8% EQNR.NO (Equinor NOK313.10, -12.30) -- lower oil prices

        • -3.6% DEC.LN (Diversified Energy Co. £10.74, -0.40) -- lower oil prices

        • -3.1% HBR.LN (Harbour Energy £2.84, -0.09) -- lower oil prices

        • -3.0% NOVO.B.DC (Novo Nordisk DKK246.95, -7.55) -- FDA publishes Warning Letter sent to Novo Nordisk on 5-Mar

        • -2.4% VTU.LN (Vertu Motors £0.60, -0.02)

        • -2.3% VER.AV (Verbund €64.00, -1.50) -- Oddo downgrade

        • -2.2% 2020.NO (2020 Bulkers NOK135.30, -3.10) -- Feb update

        • -2.0% BP.LN (BP £5.02, -0.10) -- lower oil prices

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: CVC Capital Partners (CVC.NA), Envipco Holding (ENVI.NA), Agfa-Gevaert (AGFB.BB)

        • France: Eurazeo (RF.FP)

        • Germany: Rheinmetall (RHM.GR), Porsche (P911.GR), Uniper (UN0.GR), Henkel (HEN3.GR), Wacker Chemie (WCH.GR), Kloeckner & Co. (KCO.GR), JDC Group (JDC.GR)

        • Nordics: Clas Ohlson (CLAS.B.SS), Rederiaktiebolaget Gotland (GOTL.A.SS), Talenom (TNOM.FH), Rapala VMC (RAP1V.FH), Next Biometrics Group (NEXT.NO)

        • Southern Europe: Inditex (ITX.SM), ERG (ERG.IM), Webuild (WBD.IM), WIIT (WIIT.IM), Esprinet (PRT.IM), SYS-DAT (SYS.IM), Geox (GEO.IM)

        • Switzerland: BKW (BKW.SW), Avolta (AVOL.SW)

        • UK: Legal & General Group (LGEN.LN), Hochschild Mining (HOC.LN), Balfour Beatty (BBY.LN), Canal+ SA (CAN.LN), Hill & Smith (HILS.LN), Breedon Group (BREE.LN), 4imprint Group (FOUR.LN), Forterra Plc (FORT.LN), Gym Group (GYM.LN), Robert Walters (RWA.LN)

      • Trading Update:

        • France: Sword Group (SWP.FP), Groupe Partouche (PARP.FP)

      • Traffic:

        • Flughafen Zuerich (FHZN.SW), Heathrow Airport (+HTR.LN)

      • CMD/Events: Allfunds Group (ALLFG.NA), Mota-Engil (EGL.PL), SynAct Pharma (SYNACT.SS)

  • Data:

    • Economics:

      • Denmark Feb CPI +0.7% y/y vs consensus +0.5% and prior +0.8%

      • Jan Trade Balance

        • Germany €21.2B vs consensus €15.2B and prior €17.1B

        • France (€1.8B) vs consensus (€4.6B) and prior revised (€4.3B) from (€4.8B)

      • Jan Industrial Production

        • Sweden +1.9% y/y vs consensus +3.6% and prior +4.2%

        • Austria +0.3% y/y vs consensus (0.7%) and prior (3.3%)

    • Markets:

      • WTI Crude (Apr 26): ($10.54) or (11.12%) to $84.23

      • €-$ +0.0012 or +0.10% to 1.1650

      • £-$ +0.0024 or +0.18% to 1.3459

      • €-£ (0.0005) to 0.8656

      • S&P 500 +0.46%

      • Performance year-to-date

        • FTSE 100: +4.84%

        • DAX: (2.13%)

        • CAC: (1.13%)

        • MIB: +0.57%

        • Stoxx 600: +2.35%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.